文献速递胸部肿瘤放疗中枢神经肿瘤放疗

局限期小细胞肺癌失败模式:TNM分期对预防性颅脑照射的启示

Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation.
PubMed 文献 · Radiother Oncol · 2017-08-01

该研究回顾283例I-IIIB期小细胞肺癌患者,采用竞争风险回归分析局部、远处和脑失败。结果显示I/II期患者生存显著优于III期,5年脑转移累积发生率分别为12%和26%,TNM分期独立预测生存、远处转移和脑转移风险。

要点

  • I/II期患者5年脑转移累积发生率为12%,III期为26%。
  • TNM分期与局部失败无相关性,但独立预测生存、远处和脑转移风险。
  • 早期(I/II期)脑转移风险较低,预防性颅脑照射的作用可能更有限。

核心结论

  • TNM分期可预测局限期小细胞肺癌的远处转移、脑转移和生存,支持常规使用TNM分期。
  • I和II期小细胞肺癌脑转移风险较低,预防性颅脑照射在早期疾病治疗中的作用可能更有限。

研究设计与样本

  • 回顾性分析283例I-IIIB期小细胞肺癌患者。
  • 采用竞争风险回归分析局部、远处和脑失败,多因素分析评估治疗和临床因素对失败和OS的影响。

主要发现

  • I或II期患者(占队列35%)相比III期患者生存显著更好,远处和脑转移风险显著更低。
  • I/II期和III期的5年脑转移累积发生率分别为12%和26%。
  • 分期与局部失败无相关性。
  • 多因素分析中,分期是生存、远处转移风险和脑转移风险的独立预后因素。

临床怎么用

  • 临床实践中应常规使用TNM分期对局限期小细胞肺癌进行预后评估。
  • 对于I和II期患者,考虑预防性颅脑照射时需权衡其较低的脑转移风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The relationship between tumor-node-metastasis (TNM) stage and patterns of failure in limited-stage small cell lung cancer (LS-SCLC) remains unclear. We hypothesized that TNM stage predicts brain metastasis risk, and could inform the use of prophylactic cranial irradiation. MATERIAL AND METHODS: We reviewed 283 patients with stage I-IIIB SCLC. Competing-risks regression was used to analyze local, distant, and brain failure. Multivariate analysis was used to evaluate the effect of treatment and clinical factors on failure and OS. RESULTS: Patients with stage I or II SCLC (35% of cohort) had significantly better survival and lower risk of distant and brain metastasis, compared with stage III patients. The 5-year cumulative incidence of brain metastasis for stage I/II and III were 12% and 26%, respectively. Stage had no correlation with local failure. On multivariate analysis, stage was independently prognostic for survival, distant metastasis risk, and brain metastasis risk. CONCLUSIONS: TNM staging predicts likelihood of distant metastasis, brain metastasis, and survival in LS-SCLC. This supports the routine use of TNM staging in clinical practice. The lower risk of brain metastasis in stage I and II SCLC suggests that prophylactic cranial irradiation could play a more limited role in treatment of early-stage disease.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wu AJ, Gillis A, Foster A, et al. Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation. Radiother Oncol. 2017. PMID: 28778345. doi:10.1016/j.radonc.2017.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。